News Updates

More Articles Back to Article

ViiV, Medicines Patent Pool in licensing deal for cabotegravir

ViiV Healthcare, a GSK unit, has entered into a voluntary licensing agreement with the Medicines Patent Pool to broaden access to HIV prevention in developing countries. The deal covers patents for long-acting cabotegravir as an HIV pre-exposure prophylaxis, with select generic drugmakers to be granted the chance to develop, manufacture and supply cheaper versions of the drug in 90 countries, subject to regulatory approvals. PMLive (UK) (8/1)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!